Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men.

PubWeight™: 3.18‹?› | Rank: Top 1%

🔗 View Article (PMID 14767822)

Published in J Infect Dis on January 29, 2004

Authors

Bethany A Weaver1, Qinghua Feng, King K Holmes, Nancy Kiviat, Shu-Kuang Lee, Christine Meyer, Mike Stern, Laura A Koutsky

Author Affiliations

1: Center for AIDS & STD Research, Department of Medicine, University of Washington, Harborview Medical Center, 325 9th Avenue, Box 359931, Seattle, WA 98104 USA. bethanyg@u.washington.edu

Articles citing this

Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med (2009) 8.26

The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev (2008) 3.93

Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision. Arch Pediatr Adolesc Med (2010) 3.84

Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet (2011) 3.52

Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis (2008) 3.19

Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. J Infect Dis (2010) 2.70

Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis (2008) 2.58

Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine (2008) 2.13

The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis (2007) 2.11

Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis (2008) 1.93

Circumcision of HIV-infected men: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda. J Infect Dis (2010) 1.92

Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health (2007) 1.78

Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J Infect Dis (2009) 1.74

The Strong Protective Effect of Circumcision against Cancer of the Penis. Adv Urol (2011) 1.63

Risk factors for anogenital human papillomavirus infection in men. J Infect Dis (2007) 1.59

Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr (2010) 1.54

Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health (2010) 1.53

Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men. J Clin Microbiol (2006) 1.46

Detection of human papillomavirus DNA in urine. A review of the literature. Eur J Clin Microbiol Infect Dis (2011) 1.36

Human papillomavirus detection by penile site in young men from Kenya. Sex Transm Dis (2007) 1.28

Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS One (2012) 1.28

Male circumcision for HIV prevention: current research and programmatic issues. AIDS (2010) 1.24

Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect (2006) 1.21

Genital HPV infection and related lesions in men. Prev Med (2011) 1.19

Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda. Int J Cancer (2011) 1.17

Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int J Cancer (2010) 1.17

Genital transmission of human papillomavirus in recently formed heterosexual couples. J Infect Dis (2011) 1.15

Human papillomavirus concordance in heterosexual couples. J Adolesc Health (2010) 1.07

Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain. Sex Transm Infect (2012) 1.07

Serum antibody response following genital {alpha}9 human papillomavirus infection in young men. J Infect Dis (2011) 1.05

Reduced clearance of penile human papillomavirus infection in uncircumcised men. J Infect Dis (2010) 1.01

Monitoring human papillomavirus prevalence in urine samples: a review. Clin Epidemiol (2013) 1.00

Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol (2009) 1.00

Examining the development and sexual behavior of adolescent males. J Adolesc Health (2010) 0.97

Human papillomavirus infection in men residing in Brazil, Mexico, and the USA. Salud Publica Mex (2008) 0.93

Human papillomavirus genital infections among men, China, 2007-2009. Emerg Infect Dis (2013) 0.91

Evaluation of transported dry and wet cervical exfoliated samples for detection of human papillomavirus infection. J Clin Microbiol (2010) 0.91

Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States. Int J Cancer (2012) 0.90

Circumcision and acquisition of human papillomavirus infection in young men. Sex Transm Dis (2011) 0.87

Does Male Circumcision Protect against Sexually Transmitted Infections? Arguments and Meta-Analyses to the Contrary Fail to Withstand Scrutiny. ISRN Urol (2014) 0.86

Human papillomavirus infection in a male population attending a sexually transmitted infection service. PLoS One (2013) 0.85

Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa. J Clin Virol (2013) 0.85

Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study. BMC Infect Dis (2013) 0.85

Male Circumcision and STI Acquisition in Britain: Evidence from a National Probability Sample Survey. PLoS One (2015) 0.84

Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis. J Infect Dis (2014) 0.82

Male circumcision and the incidence and clearance of genital human papillomavirus (HPV) infection in men: the HPV Infection in men (HIM) cohort study. BMC Infect Dis (2014) 0.82

Improving oral human papillomavirus detection using toothbrush sampling in HIV-positive men who have sex with men. J Clin Microbiol (2014) 0.82

Relationship between circumcision and human papillomavirus infection: a systematic review and meta-analysis. Asian J Androl (2016) 0.80

Genetic influences on brain developmental trajectories on neuroimaging studies: from infancy to young adulthood. Brain Imaging Behav (2014) 0.80

Distribution of genital human papillomavirus genotypes in benign clinical manifestations among men from Northern Spain. BMC Public Health (2016) 0.78

Sexually transmitted infections and male circumcision: a systematic review and meta-analysis. ISRN Urol (2013) 0.78

Rome Consensus Conference - statement; human papilloma virus diseases in males. BMC Public Health (2013) 0.77

Is prostatic adenocarcinoma in a relationship with Human Papilloma Virus in Isfahan -Iran. J Res Med Sci (2013) 0.76

Difficulties in estimating the male-to-female sexual transmissibility of human papillomavirus infection. Sex Transm Dis (2009) 0.76

Human papillomavirus DNA positivity and seropositivity in rural Chinese men and women: a population-based cross-sectional study. Sci Rep (2016) 0.75

Genital Human Papillomavirus Infection in Indian HIV-Seropositive Men Who Have Sex With Men. Sex Transm Dis (2017) 0.75

Multiple Human Papillomavirus Infection Is Associated with High-Risk Infection in Male Genital Warts in Ulsan, Korea. J Korean Med Sci (2016) 0.75

Articles by these authors

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med (2007) 12.17

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep (2009) 11.30

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol (2005) 9.67

Global health in medical education: a call for more training and opportunities. Acad Med (2007) 8.85

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol (2003) 7.35

Global health training and international clinical rotations during residency: current status, needs, and opportunities. Acad Med (2009) 6.31

Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med (2006) 5.69

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis (2009) 5.09

Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol (2006) 4.33

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst (2010) 4.20

Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med (2005) 3.96

The epidemiology of human papillomavirus infections. J Clin Virol (2005) 3.63

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis (2009) 3.55

Human L1 element target-primed reverse transcription in vitro. EMBO J (2002) 3.54

Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis (2007) 3.48

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ (2010) 3.41

Update on syphilis: resurgence of an old problem. JAMA (2003) 3.31

Association between Mycoplasma genitalium and acute endometritis. Lancet (2002) 3.27

Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis (2008) 3.19

Partner reduction is crucial for balanced "ABC" approach to HIV prevention. BMJ (2004) 3.12

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet (2007) 3.10

HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. AIDS (2002) 3.03

Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med (2008) 2.98

Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis (2003) 2.88

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep (2002) 2.86

Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol (2008) 2.80

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine (2006) 2.78

Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst (2006) 2.67

A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis (2004) 2.62

Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck (2009) 2.59

"It takes a village": understanding concurrent sexual partnerships in Seattle, Washington. Sex Transm Dis (2002) 2.56

Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis (2005) 2.51

Sex partner concurrency: measurement, prevalence, and correlates among urban 18-39-year-olds. Sex Transm Dis (2002) 2.46

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) (2009) 2.42

Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci U S A (2004) 2.39

Genital human papillomavirus infection in men. Lancet Infect Dis (2006) 2.39

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA (2002) 2.37

Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy. Sex Transm Dis (2006) 2.21

Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis (2008) 2.21

Do people really know their sex partners? Concurrency, knowledge of partner behavior, and sexually transmitted infections within partnerships. Sex Transm Dis (2004) 2.19

Sexual identity and risk of HIV/STI among men who have sex with men in Nairobi. Sex Transm Dis (2008) 2.11

Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis (2002) 2.09

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine (2008) 2.09

Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep (2004) 2.05

Discord, discordance, and concurrency: comparing individual and partnership-level analyses of new partnerships of young adults at risk of sexually transmitted infections. Sex Transm Dis (2005) 2.05

Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey. Lancet Infect Dis (2012) 2.03

Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis (2002) 1.99

Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol (2003) 1.91

Text messaging to improve attendance at post-operative clinic visits after adult male circumcision for HIV prevention: a randomized controlled trial. PLoS One (2012) 1.85

Handheld computers for self-administered sensitive data collection: a comparative study in Peru. BMC Med Inform Decis Mak (2008) 1.82

Comprehensive health care for people infected with HIV in developing countries. BMJ (2002) 1.81

Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial. Lancet (2012) 1.80

Epidemic Lymphogranuloma venereum during epidemics of crack cocaine use and HIV infection in the Bahamas. Sex Transm Dis (2002) 1.79

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect (2011) 1.78

Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health (2007) 1.78

Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomarkers Prev (2011) 1.74

Measuring sex partner concurrency: it's what's missing that counts. Sex Transm Dis (2007) 1.73

Determinants and prevalence of HIV infection in pregnant Peruvian women. AIDS (2003) 1.72

Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis (2003) 1.70

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol (2006) 1.69

Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance. Ann Intern Med (2007) 1.69

Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? J Infect Dis (2005) 1.69

Anal intercourse among young heterosexuals in three sexually transmitted disease clinics in the United States. Sex Transm Dis (2009) 1.68

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin (2009) 1.66

Design and implementation of Cell-PREVEN: a real-time surveillance system for adverse events using cell phones in Peru. AMIA Annu Symp Proc (2005) 1.65

Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. J Natl Cancer Inst (2009) 1.65

Importance of sex partner HIV status in HIV risk assessment among men who have sex with men. J Acquir Immune Defic Syndr (2004) 1.64

Sentinel surveillance of sexually transmitted infections/HIV and risk behaviors in vulnerable populations in 5 Central American countries. J Acquir Immune Defic Syndr (2007) 1.63

Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. Am J Transplant (2005) 1.63

Training pharmacy workers in recognition, management, and prevention of STDs: district-randomized controlled trial. Bull World Health Organ (2004) 1.63

Obtaining sensitive data through the Web: an example of design and methods. Epidemiology (2002) 1.61

Measures of sexual partnerships: lengths, gaps, overlaps, and sexually transmitted infection. Sex Transm Dis (2006) 1.61

Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Int J STD AIDS (2004) 1.61

Independent association of hygiene, socioeconomic status, and circumcision with reduced risk of HIV infection among Kenyan men. J Acquir Immune Defic Syndr (2006) 1.60

Correlates of national HIV seroprevalence: an ecologic analysis of 122 developing countries. J Acquir Immune Defic Syndr (2004) 1.59

Transmission of STIs/HIV at the partnership level: beyond individual-level analyses. J Urban Health (2003) 1.58

From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis (2008) 1.58

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med (2002) 1.57

Electronic human immunodeficiency virus (HIV) clinical reminder system improves adherence to practice guidelines among the University of Washington HIV Study Cohort. Clin Infect Dis (2003) 1.56

Clandestine induced abortion: prevalence, incidence and risk factors among women in a Latin American country. CMAJ (2009) 1.55

Reproductive tract infections in rural women from the highlands, jungle, and coastal regions of Peru. Bull World Health Organ (2004) 1.54

Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR Surveill Summ (2016) 1.54

Spatial bridges for the importation of gonorrhea and chlamydial infection. Sex Transm Dis (2003) 1.54

Bead-based ELISA for validation of ovarian cancer early detection markers. Clin Cancer Res (2006) 1.52

Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA. Clin Chem (2004) 1.50

The effect of vaginal speculum lubrication on the rate of unsatisfactory cervical cytology diagnosis. Obstet Gynecol (2002) 1.49

Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis (2012) 1.48